ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Compass Minerals International, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – CMP
May 26, 2024 14:00 ET
|
The Rosen Law Firm PA
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Compass Minerals International, Inc. (NYSE: CMP)...
Global Precision Oncology Market Size To Exceed USA 260.5 Billion By 2033 | CAGR Of 10.21%
May 26, 2024 14:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 26, 2024 (GLOBE NEWSWIRE) -- The Global Precision Oncology Market Size is to Grow from USD 98.5 Billion in 2023 to USD 260.5 Billion by 2033, at a Compound Annual...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Equity LifeStyle Properties, Inc. Investors to Inquire About Securities Class Action Investigation – ELS
May 26, 2024 13:15 ET
|
The Rosen Law Firm PA
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Equity...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TDOC
May 26, 2024 11:35 ET
|
The Rosen Law Firm PA
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock of Teladoc...
ROSEN, THE FIRST FILING FIRM, Encourages Harbor Diversified, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – HRBR
May 26, 2024 11:31 ET
|
The Rosen Law Firm PA
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Harbor Diversified, Inc. (OTC: HRBR) between May 10, 2022...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF
May 26, 2024 11:17 ET
|
The Rosen Law Firm PA
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between...
Contact Hagens Berman by May 31, 2024 Deadline to Join Class Action Against Luna Innovations (LUNA)
May 26, 2024 11:13 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 26, 2024 (GLOBE NEWSWIRE) -- Hagens Berman announces that the firm has filed a new class action lawsuit against Luna Innovations Incorporated (NASDAQ: LUNA) and certain of its...
ETmeta platform version 1.0 is officially launched
May 26, 2024 10:30 ET
|
ETmeta
New York, NY, May 26, 2024 (GLOBE NEWSWIRE) -- Recently, ETmeta platform version 1.0 is officially launched. Mr. Alexander Smith, CEO of the ETmeta platform, unveiled a brand-new model for sports...
CMBM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Cambium Networks Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 26, 2024 10:15 ET
|
Robbins Geller Rudman & Dowd LLP
SAN DIEGO, May 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Cambium Networks Corporation (NASDAQ: CMBM) securities...
Ultimate Investment Guide: Furrever Token Set to Achieve Bitcoin and Ethereum-Level ROI in 2024
May 26, 2024 10:00 ET
|
Furrever Token
New York City, NY, May 26, 2024 (GLOBE NEWSWIRE) -- Bitcoin (BTC) has fallen below $68,000, trading at $67,183 with a 3% decrease in the last 24 hours, raising concerns of a potential downtrend....
- May 25, 2024 09:40 ET Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)